Search

Immunomodulating Anticancer Alkylating Drugs: Targets and Mechanisms of Activity

Journal: Current Drug Targets
Volume: 2 Issue: 2 Year: 2001 Page: 197-212
Author(s): S. Ben-Efraim

Enzyme / Abzyme Prodrug Activation Systems: Potential Use in Clinical Oncology

Journal: Current Pharmaceutical Design
Volume: 9 Issue: 2 Year: 2003 Page: 2113-2130
Author(s): Yoshisuke Nishi

Subject Index To Volume 2

Journal: Current Drug Targets
Volume: 3 Issue: 1 Year: 2002 Page: 97-97
Author(s): Bentham Science Publishers

Nucleoside Phosphate-Conjugates Come of Age: Catalytic Transformation, Polymerase Recognition and Antiviral Properties

Journal: Current Medicinal Chemistry
Volume: 22 Issue: 34 Year: 2015 Page: 3980-3990
Author(s): Elisabetta Groaz,Piet Herdewijn Rega

Quinoline as a Privileged Scaffold in Cancer Drug Discovery

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1488-1508
Author(s): V. R. Solomon, H. Lee

Cinnamic Acid Derivatives as Anticancer Agents-A Review

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1672-1703
Author(s): P. De, M. Baltas, F. Bedos-Belval

Synthesis, Antimicrobial Activities and Molecular Docking Studies of Novel 6-Hydroxybenzofuran-3(2H)-one Based 2,4-Disubstituted 1,3- Thiazoles

Journal: Letters in Drug Design & Discovery
Volume: 10 Issue: 9 Year: 2013 Page: 798-807
Author(s): Krzysztof Z. La czkowski, Konrad Misiura, Anna Biernasiuk, Anna Malm, Agata Siwek, Tomasz Plech

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 120-133
Author(s): Bernhard A. Muller

Prodrug Design of Phenolic Drugs

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 2033-2052
Author(s): J.M. Ferriz, J. Vinsova

Imidazole Showing its Therapeutic Voyage as Anticancer Heterocyclic Ring

Ebook: Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II
Volume: 2 Year: 2022
Author(s):
Doi: 10.2174/9789815040043122020007